Professional coaching conducted in small groups can reduce physician burnout by as much as 30%, a study suggests.

The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...

The FDA has decided not to approve vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.

While the accelerated approval pathway has enabled faster access to promising oncology drugs, meaningful improvements in survival or quality of life often remain unproven, even after full approval,” ...

Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.

This analysis indicates that proposed Medicaid reforms would have far-reaching consequences beyond federal budget savings, including negative health outcomes, economic losses, and health care system ...

Researchers recommend that details on prescription medications received in the year before diagnosis and treatment initiation be included in clinical trials as essential baseline information.

Researchers recommended that regulators consider mandating head-to-head trials comparing next-in-class and against existing in-class agents when possible.

Researchers assessed the global burden of breast cancer in boys and men aged 15-64 years between 1990 and 2021.

The Trump administration’s immigration policies are having negative effects on health care, impacting patients and health care workers alike.

The FDA has decided not to approve glofitamab plus gemcitabine and oxaliplatin to treat certain patients with relapsed/refractory DLBCL.

The study results “indicate that the public has certain reservations about the integration of AI in health care,” the researchers wrote.